Tenet Healthcare (THC) Could Be 10% Undervalued As Raised Guidance Lifts The Valuation Case
Tenet Healthcare (THC) just delivered third quarter 2026 earnings that showed sales of US$5.63b and net income of US$1.0b, alongside a raised full year earnings outlook and higher projected net operating revenues.
Recent trading has been strong for Tenet Healthcare, with a year to date share price return of 33.71% and a three year total shareholder return of very large magnitude. This suggests rising optimism that the upgraded 2026 guidance and higher earnings are reshaping how investors view the company’s risk and reward profile.
Scan how Tenet Healthcare’s earnings shift compares to peers by reviewing our curated 35 high quality undervalued stocks built around companies that combine stronger cash generation with sturdier balance sheets.
The key tension now is clear. Are traders reacting mostly to Tenet Healthcare’s stronger recent earnings profile, or has sentiment simply swung too far as enthusiasm builds?
Most Popular Narrative: 9% Undervalued
Tenet Healthcare closed at $266.69, compared with a widely followed fair value estimate of $294. The current price therefore sits below where that narrative framework suggests the stock is worth based on its earnings and cash flow outlook.
Capital deployment plans include more than US$300 million of USPI M&A spend in 2026 and US$1.36b already allocated to repurchase almost 7 million shares in the first half of 2026, with a further US$2b buyback authorization. This could reduce balance sheet flexibility if operating trends weaken and affect future earnings, free cash flow and leverage metrics.
See why 1 investors see Tenet Healthcare as 9% undervalued.
Result: Fair Value of $294 (UNDERVALUED)
Still, the story can change quickly if exchange revenues and admissions that already declined by double digits keep shifting patients into the uninsured bucket, or if rising dependence on supplemental Medicaid payments leaves Tenet Healthcare more exposed to policy timing and rate decisions.
Find out about the key risks to this Tenet Healthcare narrative.
Next Steps
Sentiment on Tenet Healthcare is clearly mixed, with risks and rewards pulling in opposite directions. Act while the details are fresh and weigh the evidence yourself by reviewing the 3 key rewards and 4 important warning signs
Looking for more investment ideas beyond Tenet Healthcare?
Do not stop your research with Tenet Healthcare. Broaden your watchlist with focused stock ideas built from clear fundamentals using the Simply Wall Street Screener.
- Target steadier compounding by reviewing companies that score well on resilience and downside risk through the 30 resilient stocks with low risk scores.
- Hunt for quality at a sensible price by scanning the 19 high quality undiscovered gems built around strong fundamentals that the market may be overlooking.
- Strengthen your core holdings by using the list of solid balance sheet and fundamentals (23 results) to focus on businesses with sturdier financial footing and cleaner balance sheets.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com